Display options
Share it on

BMC Med Genomics. 2008 Jun 25;1:27. doi: 10.1186/1755-8794-1-27.

Molecular analysis of the vaginal response to estrogens in the ovariectomized rat and postmenopausal woman.

BMC medical genomics

Scott A Jelinsky, Sung E Choe, Judy S Crabtree, Monette M Cotreau, Ewa Wilson, Kathryn Saraf, Andrew J Dorner, Eugene L Brown, Bryan J Peano, Xiaochun Zhang, Richard C Winneker, Heather A Harris

Affiliations

  1. Biological Technologies, Wyeth Research, Cambridge, USA. [email protected]

PMID: 18578861 PMCID: PMC2453134 DOI: 10.1186/1755-8794-1-27

Abstract

BACKGROUND: Vaginal atrophy (VA) is the thinning of the vaginal epithelial lining, typically the result of lowered estrogen levels during menopause. Some of the consequences of VA include increased susceptibility to bacterial infection, pain during sexual intercourse, and vaginal burning or itching. Although estrogen treatment is highly effective, alternative therapies are also desired for women who are not candidates for post-menopausal hormone therapy (HT). The ovariectomized (OVX) rat is widely accepted as an appropriate animal model for many estrogen-dependent responses in humans; however, since reproductive biology can vary significantly between mammalian systems, this study examined how well the OVX rat recapitulates human biology.

METHODS: We analyzed 19 vaginal biopsies from human subjects pre and post 3-month 17beta-estradiol treated by expression profiling. Data were compared to transcriptional profiling generated from vaginal samples obtained from ovariectomized rats treated with 17beta-estradiol for 6 hrs, 3 days or 5 days. The level of differential expression between pre- vs. post- estrogen treatment was calculated for each of the human and OVX rat datasets. Probe sets corresponding to orthologous rat and human genes were mapped to each other using NCBI Homologene.

RESULTS: A positive correlation was observed between the rat and human responses to estrogen. Genes belonging to several biological pathways and GO categories were similarly differentially expressed in rat and human. A large number of the coordinately regulated biological processes are already known to be involved in human VA, such as inflammation, epithelial development, and EGF pathway activation.

CONCLUSION: At the transcriptional level, there is evidence of significant overlap of the effects of estrogen treatment between the OVX rat and human VA samples.

References

  1. Mol Endocrinol. 2003 Mar;17(3):309-17 - PubMed
  2. Endocrinology. 2005 Oct;146(10):4524-35 - PubMed
  3. J Steroid Biochem Mol Biol. 2006 Sep;101(1):11-21 - PubMed
  4. Endocrinology. 2003 Oct;144(10):4562-74 - PubMed
  5. Pharmacotherapy. 2001 Apr;21(4):464-80 - PubMed
  6. Trends Mol Med. 2006 Jan;12(1):17-25 - PubMed
  7. Nucleic Acids Res. 2001 Jul 15;29(14):2905-19 - PubMed
  8. Biol Reprod. 2003 Oct;69(4):1308-17 - PubMed
  9. Nucleic Acids Res. 2007 Jan;35(Database issue):D760-5 - PubMed
  10. Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13544-9 - PubMed
  11. Exp Biol Med (Maywood). 2006 May;231(5):632-40 - PubMed
  12. Expert Opin Investig Drugs. 2005 Mar;14(3):265-78 - PubMed
  13. J Biol Chem. 1996 Mar 15;271(11):6071-6 - PubMed
  14. Oncogene. 1999 Jun 10;18(23):3440-51 - PubMed
  15. J Biol Chem. 1991 Jan 5;266(1):551-8 - PubMed
  16. J Mol Endocrinol. 2005 Jun;34(3):889-908 - PubMed
  17. Mol Hum Reprod. 2003 Jan;9(1):19-33 - PubMed
  18. Mol Endocrinol. 2004 Aug;18(8):1859-75 - PubMed
  19. Maturitas. 2007 Dec 20;58(4):366-76 - PubMed
  20. Expert Opin Investig Drugs. 2005 Apr;14(4):435-48 - PubMed
  21. Nucleic Acids Res. 2005 Jan 1;33(Database issue):D39-45 - PubMed
  22. Int J Biochem Cell Biol. 2000 Aug;32(8):805-15 - PubMed
  23. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 - PubMed
  24. J Am Aging Assoc. 2002 Apr;25(2):87-99 - PubMed
  25. Nat Genet. 2004 Feb;36(2):197-204 - PubMed
  26. Drugs. 2005;65(17):2481-98 - PubMed
  27. Endocrinology. 2005 Sep;146(9):3999-4008 - PubMed
  28. Expert Opin Pharmacother. 2005 Jun;6(7):1095-106 - PubMed

Publication Types